The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
BIOGEN INC | COM | 09062X103 | 5,897 | 28,000 | SH | SOLE | 28,000 | 0 | 0 | ||
BRISTOL-MYERS SQUIBB CO | COM | 110122108 | 5,988 | 82,000 | SH | SOLE | 82,000 | 0 | 0 | ||
CARDINAL HEALTH INC | COM | 14149Y108 | 5,670 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
CIGNA CORP NEW | COM | 125523100 | 5,751 | 24,000 | SH | SOLE | 24,000 | 0 | 0 | ||
GILEAD SCIENCES INC | COM | 375558103 | 5,826 | 98,000 | SH | SOLE | 98,000 | 0 | 0 | ||
HARMONY BIOSCIENCES HLDGS IN | COM | 413197104 | 5,838 | 120,000 | SH | SOLE | 120,000 | 0 | 0 | ||
IRONWOOD PHARMACEUTICALS INC | COM CL A | 46333X108 | 8,932 | 710,000 | SH | SOLE | 710,000 | 0 | 0 | ||
KEMPHARM INC | COM NEW | 488445206 | 1,283 | 255,000 | SH | SOLE | 255,000 | 0 | 0 | ||
LA JOLLA PHARMACEUTICAL CO | COM | 503459604 | 3,019 | 707,000 | SH | SOLE | 707,000 | 0 | 0 | ||
MCKESSON CORP | COM | 58155Q103 | 9,184 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
OPIANT PHARMACEUTICALS INC | COM | 683750103 | 386 | 18,000 | SH | SOLE | 18,000 | 0 | 0 | ||
UTAH MED PRODS INC | COM | 917488108 | 5,032 | 56,000 | SH | SOLE | 56,000 | 0 | 0 |